102 related articles for article (PubMed ID: 16215894)
1. Drugs in liver disease and during albumin dialysis -MARS.
Majcher-Peszynska J; Peszynski P; Müller SC; Klammt S; Wacke R; Mitzner S; Stange J; Mundkowski R; Hehl EM; Schmidt R; Drewelow B
Z Gastroenterol; 2001 Jun; 39 Suppl 2():33-5. PubMed ID: 16215894
[No Abstract] [Full Text] [Related]
2. Treatment of split-liver recipients with poor graft function by albumin-dialysis (Mars).
Loock J; Treichel U; Gerken G; Malago M; Broelsch C; Philipp T; Heemann U
Z Gastroenterol; 2001 Jun; 39 Suppl 2():18-9. PubMed ID: 16215888
[No Abstract] [Full Text] [Related]
3. First experience in Spain with MARS in three patients with advanced liver failure.
Aviles J; Macia M; Perez F; Moreno A; Navarro JF; Morales S; Medina ML; Aguiar R; Garcia J
Z Gastroenterol; 2001 Jun; 39 Suppl 2():20-1. PubMed ID: 16215889
[No Abstract] [Full Text] [Related]
4. Preliminary results of a phase I trial evaluating an extracorporeal hepatic support device utilizing albumin dialysis.
Awad SS; Swaniker F; Bartlett RH
Z Gastroenterol; 2001 Jun; 39 Suppl 2():22-3. PubMed ID: 16215890
[No Abstract] [Full Text] [Related]
5. Successful clinical application of extracorporal albumin dialysis in a patient with benign recurrent intrahepatic cholestasis (BRIC).
Huster D; Schubert C; Achenbach H; Caca K; Mössner J; Berr F
Z Gastroenterol; 2001 Jun; 39 Suppl 2():13-4. PubMed ID: 16215886
[TBL] [Abstract][Full Text] [Related]
6. Artificial liver support as a bridge to orthotopic liver transplantation in a case of acute liver dysfunction on non-alcoholic steatohepatitis (NASH).
Gaspari R; Pennisi MA; Mignani V; Gasbarrini A; Mercurio G; Di Campli C; Conti G; Gentiloni Silveri N; Proietti R
Z Gastroenterol; 2001 Jun; 39 Suppl 2():15-7. PubMed ID: 16215887
[No Abstract] [Full Text] [Related]
7. Albumin-bound substances--a new target in liver failure therapy.
Mitzner S; Stange J; Klammt S; Peszynski P; Hickstein H; Korten G; Schmidt R
Z Gastroenterol; 2001 Jun; 39 Suppl 2():6-7. PubMed ID: 16215882
[No Abstract] [Full Text] [Related]
8. Is it worth removing albumin-bound substances in hepatic encephalopathy?
Blei AT
Z Gastroenterol; 2001 Jun; 39 Suppl 2():8. PubMed ID: 16215883
[No Abstract] [Full Text] [Related]
9. [The clinical experience with MARS and Prometheus procedures].
Hydzik P; Gawlikowski T; Ciszowski K; Sułlek M
Przegl Lek; 2007; 64(4-5):352-4. PubMed ID: 17724911
[TBL] [Abstract][Full Text] [Related]
10. Effect of extracorporeal liver support by molecular adsorbents recirculating system and Prometheus on redox state of albumin in acute-on-chronic liver failure.
Oettl K; Stadlbauer V; Krisper P; Stauber RE
Ther Apher Dial; 2009 Oct; 13(5):431-6. PubMed ID: 19788461
[TBL] [Abstract][Full Text] [Related]
11. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
[TBL] [Abstract][Full Text] [Related]
12. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure.
Stadlbauer V; Krisper P; Beuers U; Haditsch B; Schneditz D; Jung A; Putz-Bankuti C; Holzer H; Trauner M; Stauber RE
ASAIO J; 2007; 53(2):187-93. PubMed ID: 17413559
[TBL] [Abstract][Full Text] [Related]
13. [Organ replacement therapy - extracorporeal liver assist devices].
Sinner B; Kirchner GI
Anasthesiol Intensivmed Notfallmed Schmerzther; 2016 Sep; 51(9):554-62. PubMed ID: 27631450
[TBL] [Abstract][Full Text] [Related]
14. [Development of extracorporeal blood purification methods: Molecular Adsorbent Recirculating System (MARS) for hepatic and renal function replacement].
Marangoni R
G Ital Nefrol; 2007; 24 Suppl 38():92-6. PubMed ID: 17922457
[TBL] [Abstract][Full Text] [Related]
15. Proteomics in extracorporeal blood purification and peritoneal dialysis.
Thongboonkerd V
J Proteomics; 2010 Jan; 73(3):521-6. PubMed ID: 19527805
[TBL] [Abstract][Full Text] [Related]
16. Mars in decompensated alcoholic liver disease with multi-organ failure.
Jalan R; Kapoor D; Steiner C; Williams R
Z Gastroenterol; 2001 Jun; 39 Suppl 2():12. PubMed ID: 16215885
[No Abstract] [Full Text] [Related]
17. [Level of evidence for therapeutic drug monitoring of ceftriaxone].
Dailly E; Verdier MC; Deslandes G; Bouquié R; Tribut O; Bentué-Ferrer D
Therapie; 2012; 67(2):145-9. PubMed ID: 22850101
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of teicoplanin.
Fraschini F
J Chemother; 1989 Jul; 1(4 Suppl):590-2. PubMed ID: 16312547
[No Abstract] [Full Text] [Related]
19. Extracorporeal albumin dialysis in acute-on-chronic liver failure: will it stand the test of time?
Sen S; Jalan R; Williams R
Hepatology; 2002 Oct; 36(4 Pt 1):1014-6. PubMed ID: 12297853
[No Abstract] [Full Text] [Related]
20. [Prescription of drugs in liver diseases].
Held H
Internist (Berl); 1980 Dec; 21(12):724-34. PubMed ID: 7009474
[No Abstract] [Full Text] [Related]
[Next] [New Search]
